| Symbol |
Name |
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTB
|
actin, beta
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADM
|
adrenomedullin
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANXA1
|
annexin A1
|
|
ARID1B
|
AT rich interactive domain 1B (SWI1-like)
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CCK
|
cholecystokinin
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CISD2
|
CDGSH iron sulfur domain 2
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COX1
|
|
|
COX2
|
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
DMC1
|
DNA meiotic recombinase 1
|
|
EDN1
|
endothelin 1
|
|
EFNA5
|
ephrin-A5
|
|
EGF
|
epidermal growth factor
|
|
EPO
|
erythropoietin
|
|
ERGIC1
|
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FN1
|
fibronectin 1
|
|
FOXO4
|
forkhead box O4
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GAST
|
gastrin
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GPX1
|
glutathione peroxidase 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HID1
|
HID1 domain containing
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMGB1
|
high mobility group box 1
|
|
HNMT
|
histamine N-methyltransferase
|
|
HRH3
|
histamine receptor H3
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
IAPP
|
islet amyloid polypeptide
|
|
IDUA
|
iduronidase, alpha-L-
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IL11
|
interleukin 11
|
|
IL17A
|
interleukin 17A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
JAG1
|
jagged 1
|
|
KDR
|
kinase insert domain receptor
|
|
KLK1
|
kallikrein 1
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LOC105371045
|
uncharacterized LOC105371045
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGLL
|
monoglyceride lipase
|
|
MLN
|
motilin
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NRG1
|
neuregulin 1
|
|
NUCB2
|
nucleobindin 2
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
OXTR
|
oxytocin receptor
|
|
PGC
|
progastricsin (pepsinogen C)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLG
|
plasminogen
|
|
POTEF
|
POTE ankyrin domain family, member F
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PSCA
|
prostate stem cell antigen
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RBM45
|
RNA binding motif protein 45
|
|
S100A8
|
S100 calcium binding protein A8
|
|
SDC1
|
syndecan 1
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SST
|
somatostatin
|
|
TAC1
|
tachykinin, precursor 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFF1
|
trefoil factor 1
|
|
TFF2
|
trefoil factor 2
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TNF
|
tumor necrosis factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VGF
|
VGF nerve growth factor inducible
|
|
VIP
|
vasoactive intestinal peptide
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
